Group 1: Industry Developments - Multiple flying car companies based in Guangzhou are making significant moves, including a new battery technology set to be applied in Xiaopeng Huitian's flying cars in Panyu District [1] - GAC Group's subsidiary, GAC Gaoyu, plans to launch a flying car demonstration operation plan within this year, aiming to create a multi-modal transportation model by 2027 [1][16] - Xiaoma Zhixing has established a strategic partnership with Dubai's Roads and Transport Authority to deploy a Robotaxi fleet, with testing set to begin in 2025 [1][16] Group 2: Technological Innovations - The "14th Five-Year Plan" key research project on high-safety, high-energy lithium-ion battery systems has been initiated, with results expected to be applied in Xiaopeng Huitian's next-generation flying cars [15] - The project will utilize the "top-flow cylindrical" technology route developed by Zhongchuang Innovation [15] Group 3: Economic Indicators - The National Bureau of Statistics reported that from January to April, the total profit of large-scale industrial enterprises in China reached 21,170.2 billion yuan, reflecting a year-on-year increase of 1.4% [8] - Among these, state-owned enterprises saw a profit of 7,022.8 billion yuan, down 4.4%, while private enterprises reported a profit increase of 4.3% to 5,706.8 billion yuan [8]

Core Viewpoint - Angel Yeast is advancing its biotechnology development by launching a core technology project for serum-free cell culture media, with an estimated total investment of 230 million yuan, aiming to transform its business from a fermentation raw material supplier to a provider of integrated solutions in the biotechnology field [1][2]. Group 1: Biotechnology Development - The company plans to implement a core technology project for serum-free cell culture media, targeting the preparation needs for antibodies, vaccines, and recombinant proteins [2]. - The project will upgrade the existing synthetic biology pilot platform at the Yichang High-tech Zone and add new preparation platforms for serum-free cell culture media and core raw material purification [2]. - The project is expected to have an annual production capacity of 200 tons of dry powder serum-free cell culture media and 100,000 liters of liquid serum-free cell culture media, with a construction period of 30 months and production expected to start in 2027 [2]. Group 2: Financial Performance - In 2024, Angel Yeast is projected to achieve a revenue of 15.197 billion yuan, representing a year-on-year growth of 11.86%, and a net profit of 1.325 billion yuan, with a growth of 4.07% [3]. - For the first quarter of this year, the company reported total revenue of 3.794 billion yuan, an increase of 8.95%, and a net profit of 370 million yuan, up 16.02% year-on-year [3]. Group 3: Product Expansion - The company is expanding its product boundaries, having developed yeast protein that has been included in the new food raw material directory by the National Health Commission [4]. - Angel Yeast's yeast protein is exported to over 40 countries and regions and is used in various food products, including protein powders and dietary supplements [4]. - The company is also constructing a large-scale PHA (polyhydroxyalkanoates) industrialization project, which is seen as an ideal alternative to traditional plastics [4].

Group 1 - The main consumption index (000932) has shown a slight increase of 0.14% as of May 27, 2025, with notable gains in stocks such as Yanjing Beer (2.89%) and Angel Yeast (2.85%) [1] - The major consumption ETF (159672) has risen by 4.04% over the past three months, indicating a positive trend in consumer sector investments [1] - Huatai Securities expresses optimism regarding the food and beverage industry during the economic transition towards consumption, supported by clear policies and steady growth in retail sales [1] Group 2 - The major consumption ETF closely tracks the main consumption index and is categorized into 11 primary and 35 secondary industries, providing a comprehensive analysis tool for investors [2] - Since its inception, the major consumption ETF has achieved a maximum monthly return of 24.35% and an average monthly return of 5.36% [2] - The current price-to-earnings ratio (PE-TTM) of the major consumption index is 19.75, indicating a valuation lower than 95.63% of the past year, suggesting historical low valuations [2] Group 3 - As of April 30, 2025, the top ten weighted stocks in the main consumption index account for 67.16% of the total index, with Yili (10.39%) and Kweichow Moutai (10.39%) being the largest contributors [3] - The top ten stocks include notable companies such as Wuliangye and Moutai, reflecting the concentration of market weight in a few key players [3][5]

证券代码：600298 证券简称：安琪酵母 公告编号：2025-053 号 安琪酵母股份有限公司 关于实施无血清细胞培养基核心技术攻关工程 项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 依法承担法律责任。 重要内容提示： ●项目名称：无血清细胞培养基核心技术攻关工程项目 ●项目金额：项目总投资估算 23,000 万元 ●特别风险提示：技术成果转化风险、市场开发不及预期 的风险 一、项目概述 （五）本项目不属于关联交易和重大资产重组事项。 二、项目基本情况 （一）基本方案 1.项目内容：项目面向抗体、疫苗、重组蛋白等生物制品 制备需求，在宜昌高新区安琪生物产业园现有合成生物中试平 台基础上进行升级改造，新增无血清细胞培养基制备平台和无 血清培养基核心原料精制纯化平台，并在公司现有研发基础上 新增相关研发设备。项目拟购置发酵、分离、提取、制备、检 验检测等核心工艺关键设备，成果转化能力为年产干粉无血清 细胞培养基 200 吨、液体无血清细胞培养基 10 万升。 2.项目选址：公司宜昌安琪生物产业园厂区内预留生产用 地，具体情况以实 ...

证券代码：600298 证券简称：安琪酵母 公告编号：2025-054 号 安琪酵母股份有限公司 2025 年第一季度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 承担法律责任。 安琪酵母股份有限公司（以下简称公司）于 2025 年 5 月 26 日（星期一）13:45-14:45 在上海证券交易所上证路演中心（网 址：http://roadshow.sseinfo.com/），以视频直播和网络文字 互动方式召开了 2025 年第一季度业绩说明会。关于本次业绩说 明会的召开事项，详见公司于 2025 年 5 月 9 日在上海证券交易 所网站（www.sse.com.cn）上披露的《安琪酵母股份有限公司关 于召开 2025 年第一季度业绩说明会的公告》（2025-048 号）。 现将召开情况公告如下： 一、业绩说明会召开情况 2025 年 5 月 26 日，公司董事长熊涛、总经理肖明华、独立 董事涂娟、财务负责人姜德玉、董事会秘书高路出席了本次业绩 说明会，与投资者进行互动交流和沟通，就投资者关注的问题在 信息披露 ...

证券代码：600298 证券简称：安琪酵母 公告编号：2025-052 号 安琪酵母股份有限公司 第十届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 一、董事会会议召开情况 安琪酵母股份有限公司（以下简称公司）于2025年5月22日 以邮件的方式发出召开第十届董事会第二次会议的通知。会议于 2025年5月26日上午以现场与通讯相结合的方式在公司五楼会议 室召开。本次会议应参会董事11名，实际参会董事11名，其中以 通讯表决方式出席会议的董事6名。会议由董事长熊涛主持，公 司部分高级管理人员列席了会议。 本次会议审议了相关议案并进行了逐项表决，其中议案二审 议表决时关联董事回避表决，非关联董事一致通过。本次会议的 召集和召开符合《中华人民共和国公司法》《安琪酵母股份有限 公司章程》《安琪酵母股份有限公司董事会议事规则》的有关规 定，会议决议有效。 本议案尚需提交公司股东会审议。 （二）关于调整公司独立董事津贴的议案 二、董事会会议审议情况 （一）关于公司实施无血清细胞培养基核心技术攻关工程项 目的议 ...

Core Viewpoint - Angel Yeast is a significant player in the global yeast market, controlling one-fifth of the world's yeast production capacity and ranking second in market share. The company is not just selling yeast but is also addressing the global protein supply crisis, which is becoming increasingly critical for human survival in the 21st century [2][4][6]. Group 1: Protein Supply Challenges - The current protein supply in China heavily relies on imported feed, particularly soybeans, with domestic production being insufficient to meet demand. This dependency creates vulnerabilities in the food supply chain [4][5]. - Over the past thirty years, China's soybean imports have surged twentyfold, significantly benefiting major grain traders in the West. The import of whey protein has also increased dramatically, indicating a reliance on foreign sources for quality protein [5][6]. - The protein supply chain is at risk, as global demand for quality protein continues to rise, and any disruption in imports could lead to severe shortages and price increases [8][9]. Group 2: Angel Yeast's Innovative Approach - Angel Yeast is leveraging industrial methods to produce protein through yeast, which does not require arable land and has a lower carbon footprint compared to traditional livestock farming. This approach allows for continuous production without dependence on weather conditions [9][10]. - The company is cultivating high-protein yeast strains that can produce protein efficiently, avoiding the risks associated with allergens and antibiotic residues found in traditional animal protein sources [9][10]. - By creating a closed-loop ecosystem, Angel Yeast is transforming the protein supply landscape, providing a sustainable alternative that could alleviate reliance on international suppliers and enhance food security [11][12]. Group 3: Market Implications - The emergence of yeast protein could lead to a restructuring of the entire protein supply chain, potentially lowering prices for traditional protein sources like soy and whey as competition increases [10][11]. - Angel Yeast's innovations represent a shift in the industry, where the focus is on industrial production rather than agricultural yield, thus changing the dynamics of protein supply and demand [12]. - The company's advancements in yeast protein production could position it as a leader in the global protein market, offering solutions that meet the growing needs of consumers while reducing environmental impact [12].

Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm addresses the implementation of the repurchase and cancellation of part of the restricted stock under the 2024 incentive plan of Angel Yeast Co., Ltd. [1] Group 1: Decision and Disclosure Procedures - The company has completed the necessary decision-making and disclosure procedures for the repurchase and cancellation of restricted stocks, including approvals from the 37th and 39th meetings of the board [5] - The company has publicly disclosed the repurchase plan and confirmed that no creditors have claimed debts during the public notice period of 45 days [5][6] Group 2: Details of the Repurchase and Cancellation - The repurchase and cancellation involve 488,000 shares of restricted stock due to 39 incentive targets no longer meeting the conditions for incentives [6] - After the repurchase, the remaining restricted stocks under the incentive plan will total 10,988,000 shares [6] - The repurchase is expected to be completed by May 28, 2025, and the company will proceed with the necessary capital reduction registration after the cancellation [6] Group 3: Legal Conclusions - The law firm concludes that the company has fulfilled its disclosure obligations and complied with relevant regulations regarding the repurchase and cancellation of restricted stocks [6]

Group 1 - The company is implementing a repurchase and cancellation of restricted stocks due to 39 incentive targets no longer meeting the incentive conditions because of resignation and job transfers [1][2] - The repurchase involves a total of 506,200 shares, with 488,000 shares from the 2020 incentive plan and 18,200 shares from the 2024 incentive plan [2][3] - The decision for the repurchase was approved by the company's board and supervisory committee, and legal opinions were obtained confirming the compliance of the process [2][4] Group 2 - After the repurchase, the total number of shares will decrease from 868,644,671 to 868,138,471, with the remaining shares under the 2020 incentive plan being zero [3][4] - The company assures that the repurchase will not change the controlling shareholder or actual controller, and the equity distribution will still meet listing requirements [3][4] - Legal opinions confirm that the repurchase process is compliant with relevant laws and regulations, and the company will fulfill its information disclosure obligations [4][5]

湖北瑞通天元律师事务所 关于安琪酵母股份有限公司 回购注销 2020年限制性股票激励计划部分限制性股票 = 之法律意见书 | | | REDSECE | | | | | --- | --- | --- | --- | --- | --- | | | | | | | | | | 199 | ﺍﻟﻤﺴﺎﻋﺪ ﺍﻟﻤ | ﺍﻟﻤﺴﺎﻋﺪﺓ | | an a | | | | DDLAD | | | | | | | THE LE | | | | | | | | | 12 | | 敬业 勤业 精业 二〇二五年五月 t - 100 - 100 - 10 敬业 勒业 精业 湖北瑞通天元律师事务所法律意见书 释 义 湖北瑞通天元律师事务所法律意见书 湖北瑞通天元律师事务所 关于安琪酵母股份有限公司 回购注销 2020年限制性股票激励计划部分限制性股票 | 安琪酵母/公司 | 指 | 安琪酵母股份有限公司 | | --- | --- | --- | | 本事项/回购注销事项 | 指 | 回购注销部分限制性股票 | | 本计划 | 損 | 安琪酵母股份有限公司 2020年限制性股 | | | | 票激励计划 | | 《激励计划》 ...